- Home
- MYD vs AGL Comparison
MYD vs AGL Comparison
Compare MYD & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYD
- AGL
- Stock Information
- Founded
- MYD 1991
- AGL 2016
- Country
- MYD United States
- AGL United States
- Employees
- MYD N/A
- AGL N/A
- Industry
- MYD Investment Bankers/Brokers/Service
- AGL Managed Health Care
- Sector
- MYD Finance
- AGL Health Care
- Exchange
- MYD Nasdaq
- AGL Nasdaq
- Market Cap
- MYD 460.1M
- AGL 443.4M
- IPO Year
- MYD N/A
- AGL 2021
- Fundamental
- Price
- MYD $10.57
- AGL $0.96
- Analyst Decision
- MYD
- AGL Hold
- Analyst Count
- MYD 0
- AGL 20
- Target Price
- MYD N/A
- AGL $2.75
- AVG Volume (30 Days)
- MYD 253.1K
- AGL 6.6M
- Earning Date
- MYD 01-01-0001
- AGL 11-04-2025
- Dividend Yield
- MYD 4.55%
- AGL N/A
- EPS Growth
- MYD N/A
- AGL N/A
- EPS
- MYD N/A
- AGL N/A
- Revenue
- MYD N/A
- AGL $5,901,182,000.00
- Revenue This Year
- MYD N/A
- AGL N/A
- Revenue Next Year
- MYD N/A
- AGL $6.21
- P/E Ratio
- MYD N/A
- AGL N/A
- Revenue Growth
- MYD N/A
- AGL 11.76
- 52 Week Low
- MYD $8.76
- AGL $0.71
- 52 Week High
- MYD $11.30
- AGL $6.08
- Technical
- Relative Strength Index (RSI)
- MYD 52.87
- AGL 39.31
- Support Level
- MYD $10.49
- AGL $0.85
- Resistance Level
- MYD $10.70
- AGL $1.10
- Average True Range (ATR)
- MYD 0.09
- AGL 0.09
- MACD
- MYD -0.02
- AGL 0.00
- Stochastic Oscillator
- MYD 33.33
- AGL 30.33
About MYD Blackrock MuniYield Fund Inc.
Blackrock Muniyield Fund Inc is a non-diversified, closed-end management investment company. The fund's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Corporate, Health, Utilities, Education, Housing, and other sectors.
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.